Dr. Reddy's Laboratories Limited has informed the Exchange about General Updates

Regulatory & Legal View source PDF Explain this filing

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.3%Reaction day

₹1256.10

prior close

₹1261.00

announcement price

After-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)-0.2%-1.1% vs market

Pharmaceuticals peers, median of 151sector-0.5%-0.8% vs sector

On the reaction day the stock moved 1.1 pts less than Nifty 100 and 0.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.5

10m

-0.5

15m

-0.7

30m

-1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.3-0.2-1.1-0.5-0.8

Next day

-0.6+0.4-1.0-0.4-0.2

+1.0-0.2+1.2-1.0+2.0

+1.7-1.2+2.8-1.7+3.4

+2.5-1.8+4.2-2.5+5.0

+3.6-1.2+4.7-1.5+5.0

+0.9-1.4+2.3-2.2+3.1

15d

-3.0-2.6-0.4-6.4+3.4

+1.5-1.0+2.5-5.9+7.4

+3.7+0.7+2.9-4.1+7.8

+1.9+2.9-1.0-8.0+9.9

UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 151Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from the USFDA for its API manufacturing facility in Middleburgh, New York. The USFDA has classified the inspection outcome as 'Voluntary Action Indicated (VAI),' which is the most favorable classification and indicates no further regulatory action is required. The inspection, previously intimated on May 17, 2025, has now been officially closed under 21 CFR 20.64(d)(3). This removes the regulatory overhang related to this facility's compliance status.

Likely market impact

Positive for shareholders — the VAI classification is the best possible outcome and removes uncertainty around the Middleburgh facility. This typically supports stable operations and supply continuity for the company's API business serving the US market.